Sensei Biotherapeutics, Inc. (SNSE) Misses Q1 EPS by 4c

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Upgrades Infosys Ltd. (INFO:IN) (INFY) to Buy (1)
• Axis Capital Limited Upgrades Tata Elxsi Ltd (TELX:IN) to Buy (1)